Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1973 • 12,522 citations

Understanding the Dose-Effect Relationship

1981 • 1,111 citations

A sensitive and specific assay for the estimation of monoamine oxidase

1963 • 992 citations

Low-order classical Runge-Kutta formulas with stepsize control and their application to some heat transfer problems

1969 • 484 citations

Platelets as a model for neurones?

1988 • 225 citations

A Bayesian Approach to Nonlinear Random Effects Models

1985 • 117 citations

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327

1991 • 105 citations

Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain)

1987 • 62 citations

[3H]Ro 19-6327: A reversible ligand and affinity labelling probe for monoamine oxidase-B

1989 • 48 citations

Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans.

1990 • 26 citations

Characterization of [3H]Ro 16-6491 binding to digitonin solubilized monoamine oxidase-B and purification of the enzyme from human platelets by affinity chromatography

1990 • 6 citations

Mixed linear and non‐linear disposition of lazabemide, a reversible and selective inhibitor of monoamine oxidase B.

1994 • 6 citations